Trillium’s Role in the Growing Hydrogen Market

Hydrogen is considered a greener and better alternative to other forms of gas energy production. It reduces emissions and can be produced from many sources, as opposed to only fossil fuels. The hydrogen market has a promising future but there are some key areas that need to be explored with its growth.

Where is the growth of the hydrogen market headed? And how are some companies in the industry contributing?

For this episode of “Flowcast,” host Michelle Dawn Mooney interviewed two team members of Trillium: Simon Bradshaw, Global Director of Engineering and Technology, and Sanket Walimbe, Technical Development Manager. The three discussed hydrogen, its value, some of the technical challenges in utilizing it, and how it can see wider adoption across the globe.

Mooney, Bradshaw, and Walimbe further talked about:

  1. Renewable energy and its rise
  2. The potential of the hydrogen market and its value chain givens its pros and cons
  3. The future of the hydrogen market

“The cost of hydrogen is still really high compared to other methods of producing it, but the main ones are gray and black hydrogen, or blue hydrogen, which are generally derived from fossil fuels. ‘Those costs for green hydrogen are likely to reduce significantly depending on innovation and all those things within the marketplace, but it’s currently still not cost competitive,” said Bradshaw.

Walimbe added that Trillium is best equipped in preparation for the growth of the hydrogen market.

“All I would say is that we have great intelligence on this topic within our business and product line, and it can also be compatible with the application with certain modifications, and with this in hand, we are keeping an eye on how the economy is taking shape in the future so we can adapt to it as we go on,” he said.

Simon Bradshaw is the Global Director of Engineering and Technology at Trillium. He’s been with the company for a year now, and was previously the Director of Engineering at Circor Industries Americas. Bradshaw has been in the engineering industry since 1986 and is a graduate of Heriot-Watt University and also holds credentials as a Chartered Engineer from the Institution of Engineering Designers.

Sanket Walimbe is the Technical Development Manager at Trillium. He’s been with the company for close to two years now and was previously the Principal Engineer at Trelleborg Group. Walimbe is a graduate of Alliance Manchester Business School and the University of Sheffield.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More